109 related articles for article (PubMed ID: 11360647)
1. [The relationship between fetal fibronectin, bacteria vaginosis and chorioammionitis].
Wang D; Wang Z; Di H
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):399-400. PubMed ID: 11360647
[TBL] [Abstract][Full Text] [Related]
2. IL-1beta, IL-6, TNFalpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis.
Mattsby-Baltzer I; Platz-Christensen JJ; Hosseini N; Rosén P
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):701-6. PubMed ID: 9740515
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between vaginal sialidase bacteria vaginosis and chorioammionitis].
Zhang X; Xu X; Li J; Li N; Yan T; Ju X
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):588-90. PubMed ID: 12487930
[TBL] [Abstract][Full Text] [Related]
4. Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections.
Svare JA; Schmidt H; Hansen BB; Lose G
BJOG; 2006 Dec; 113(12):1419-25. PubMed ID: 17010117
[TBL] [Abstract][Full Text] [Related]
5. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor.
Stevens AO; Chauhan SP; Magann EF; Martin RW; Bofill JA; Cushman JL; Morrison JC
Am J Obstet Gynecol; 2004 Jun; 190(6):1582-7; discussion 1587-9. PubMed ID: 15284741
[TBL] [Abstract][Full Text] [Related]
6. Examining the relationship between positive mid-gestational fetal fibronectin assays and histological evidence of acute placental inflammation.
Akers A; Jarzembowski JA; Johnson CT; Lieberman RW; Dalton VK
J Perinat Med; 2007; 35(1):36-42. PubMed ID: 17313308
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
Díaz J; Chedraui P; Hidalgo L; Medina M
J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
[TBL] [Abstract][Full Text] [Related]
9. [Fetal fibronectin and preterm birth].
Luo L; Lü Q; Wei F
Zhonghua Fu Chan Ke Za Zhi; 1997 Jan; 32(1):25-6. PubMed ID: 9596866
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bacterial vaginosis does not reduce preterm birth among high-risk asymptomatic women in fetal fibronectin positive patients.
Briery CM; Chauhan SP; Magann EF; Cushman JL; Morrison JC
J Miss State Med Assoc; 2011 Mar; 52(3):72-5. PubMed ID: 21476464
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of flomoxef in the treatment of chorioamnionitis and changes in the fetal fibronectin level in vaginal secretion].
Chimura T; Hirayama T; Oda T; Saitou N; Morisaki N
Jpn J Antibiot; 1993 Feb; 46(2):164-70. PubMed ID: 8331777
[TBL] [Abstract][Full Text] [Related]
12. Effect of bacterial vaginosis on premature rupture of membranes and related complications in pregnant women with a gestational age of 37-42 weeks.
Ziaei S; Sadrkhanlu M; Moeini A; Faghihzadeh S
Gynecol Obstet Invest; 2006; 61(3):135-8. PubMed ID: 16330881
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
Mateus J; Pereira L; Baxter J; Berghella V; Tolosa J
Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
[TBL] [Abstract][Full Text] [Related]
14. The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women.
Hendler I; Andrews WW; Carey CJ; Klebanoff MA; Noble WD; Sibai BM; Hillier SL; Dudley D; Ernest JM; Leveno KJ; Wapner R; Iams JD; Varner M; Moawad A; Miodovnik M; O'Sullivan MJ; Van Dorsten PJ;
Am J Obstet Gynecol; 2007 Nov; 197(5):488.e1-5. PubMed ID: 17980184
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics and preterm labor.
Stetzer BP; Mercer BM
Clin Obstet Gynecol; 2000 Dec; 43(4):809-17. PubMed ID: 11100298
[TBL] [Abstract][Full Text] [Related]
16. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
Incerti M; Ghidini A; Korker V; Pezzullo JC
Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
[TBL] [Abstract][Full Text] [Related]
17. Bacterial vaginosis: a problematic infection from both a perinatal and neonatal perspective.
Denney JM; Culhane JF
Semin Fetal Neonatal Med; 2009 Aug; 14(4):200-3. PubMed ID: 19362525
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of bacterial vaginosis in Thai pregnant women with preterm labor in Siriraj hospital.
Thanavuth A; Chalermchockcharoenkit A; Boriboonhirunsarn D; Sirisomboon R; Pimol K
J Med Assoc Thai; 2007 Mar; 90(3):437-41. PubMed ID: 17427517
[TBL] [Abstract][Full Text] [Related]
19. [Economical impact of preterm delivery management based on fetal fibronectin results].
García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
[TBL] [Abstract][Full Text] [Related]
20. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery.
Kurtzman J; Chandiramani M; Briley A; Poston L; Das A; Shennan A
Am J Obstet Gynecol; 2009 Mar; 200(3):263.e1-6. PubMed ID: 19254585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
